Literature DB >> 18050715

[Vaccines, immunoglobulins, and test systems for the prevention and diagnosis of tick-borne encephalitis].

M S Vorob'eva, M N Rasshchepkina, I P Ladyzhenskaia.   

Abstract

The quality of drugs used in the Russian Federation to prevent and diagnose tick-borne encephalitis (TBE) was analyzed. The TBE vaccines made in Russian were shown to be as effective as those manufactured in foreign countries and to have the similar production techniques and quality indices therefore they may be interchangeable in the population's vaccination. The specific activity of has recently increased in terms of the content of TBE virus antibodies. In Russia, a wide range of enzyme immunoassay systems have been designed and manufactured for the detection of human serum (plasma) IgM and IgG antibodies to TVE virus and for that of TBE viral antigen in the biological objects, primarily in the ticks.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18050715

Source DB:  PubMed          Journal:  Vopr Virusol        ISSN: 0507-4088


  3 in total

1.  The impact of climate change on the expansion of Ixodes persulcatus habitat and the incidence of tick-borne encephalitis in the north of European Russia.

Authors:  Nikolay K Tokarevich; Andrey A Tronin; Olga V Blinova; Roman V Buzinov; Vitaliy P Boltenkov; Elena D Yurasova; Jo Nurse
Journal:  Glob Health Action       Date:  2011-10-21       Impact factor: 2.640

2.  Exploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy.

Authors:  Natalia S Pripuzova; Larissa V Gmyl; Lidiya Iu Romanova; Natalia V Tereshkina; Yulia V Rogova; Liubov L Terekhina; Liubov I Kozlovskaya; Mikhail F Vorovitch; Karina G Grishina; Andrey V Timofeev; Galina G Karganova
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

Review 3.  Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.

Authors:  Alexander Domnich; Donatella Panatto; Eva Klementievna Arbuzova; Alessio Signori; Ulderico Avio; Roberto Gasparini; Daniela Amicizia
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.